Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 1

A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up

Pages
124–133
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This retrospective study summarizes the patient characteristics, comorbidities, treatment choices, and side effects during 16 years of clinical practice.Key words: Bullous diseases epidemiology, pemphigus vulgaris, bullous pemphigoid

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Autoimmune bullous diseases, if left untreated, are life-threatening conditions affecting primarily skin and mucous membranes.
📊
Key Findings & Data:Materials and methods: Medical files were examined retrospectively for all patients with autoimmune bullous diseases who were followed up between 2003 and 2019 at the Bullous Skin Disease Center at İstanbul University, Cerrahpaşa.
💡
Conclusion & Impact:Conclusion: This retrospective study summarizes the patient characteristics, comorbidities, treatment choices, and side effects during 16 years of clinical practice.Key words: Bullous diseases epidemiology, pemphigus vulgaris, bullous pemphigoid
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Autoimmune bullous diseases, if left untreated, are life-threatening conditions affecting primarily skin and mucous membranes. These blistering disorders are characterized by epidermal or subepidermal detachment. Autoimmunity plays a key role in pathogenesis; therefore, immunosuppressive agents are the treatment of choice. The aim of this study is to document relative frequencies of different autoimmune bullous diseases, patient characteristics, treatment options, and side effects in patients presenting to our bullous skin disease center at İstanbul University, Cerrahpaşa, Cerrahpaşa Medical Faculty. Materials and methods: Medical files were examined retrospectively for all patients with autoimmune bullous diseases who were followed up between 2003 and 2019 at the Bullous Skin Disease Center at İstanbul University, Cerrahpaşa. Results: A total of 346 patient files were examined. Pemphigus vulgaris was the most frequent autoimmune bullous disease, followed by bullous pemphigoid and pemphigus foliaceus, according to our study. There is a general female predominancy for all autoimmune bullous diseases. The most commonly preferred treatment options were high-dose daily corticosteroids. Conclusion: This retrospective study summarizes the patient characteristics, comorbidities, treatment choices, and side effects during 16 years of clinical practice.Key words: Bullous diseases epidemiology, pemphigus vulgaris, bullous pemphigoid

🔖

Cite This Article

ÇELİK, U., KUTLUBAY, Z., MAT, C., KEÇİCİ, A. S. (2022). A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 1, 124–133. https://ajindex.com/articles/609944

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Marazza G, Pham HC, Schärer L, Pedrazzetti PP, Hunziker T et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. British Journal of Dermatology 2009
  2. 161 (3): 861-868. doi: 10.1111/j.1365- 2133.2009.09300.x 2. V’Lckova-Laskoska MT, Laskoski DS, Kamberova S, Biljanovska NC, Volckova N. Epidemiology of pemphigus in Macedonia: a 15-year retrospective study (1990–2004). International Journal of Dermatology 2007
  3. 46 (3): 253-258. doi:10.1111/j.1365-4632.2006.03010.x 3. Baican A, Baican C, Chiriac G, Chiriac MT, Macovei V et al. Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. International Journal of Dermatology 2010
  4. 49 (7): 768-774. doi:10.1111/j.1365- 4632.2009.04345.x 4. Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ et al. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. British Medical Journal 2008
  5. 337 (7662): a180. doi:10.1136/bmj.a180 5. Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Esmaili N, Balighi K et al. Pemphigus: analysis of 1,209 cases. International Journal of Dermatology 2005
  6. 44 (6): 470-476. doi:10.1111/j.1365-4632.2004.02501.x 6. Nanda A, Dvorak R, Al-Saeed K, Al-Sabah H, Alsaleh QA. Spectrum of autoimmune bullous diseases in Kuwait. International Journal of Dermatology 2004
  7. 43 (12): 876-881. doi:10.1111/j.1365-4632.2004.02292.x 7. Försti AK, Jokelainen J, Timonen M, Tasanen K. Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital. British Journal of Dermatology 2014
  8. 171 (5): 1223-1226. doi:10.1111/ bjd.13189 8. Daneshpazhooh M, Chams-Davatchi C, Payandemehr P, Nassiri S, Valikhani M et al. Spectrum of autoimmune bullous diseases in Iran: a 10-year review. International Journal of Dermatology 2012
  9. 51 (1): 35-41. doi:10.1111/j.1365- 4632.2011.04946.x 9. Jin P, Shao C, Ye G. Chronic bullous dermatoses in China. International Journal of Dermatology 1993
  10. 32 (2): 89-92. doi:10.1111/j.1365-4362.1993.tb01441.x 10. Adam BA. Bullous diseases in Malaysia: epidemiology and natural history. International Journal of Dermatology 1992
  11. 31 (1): 42-45. doi:10.1111/j.1365-4362.1992.tb03519.x 11. Uzun S, Durdu M, Akman A, Gunasti S, Uslular C et al. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. International Journal of Dermatology 2006
  12. 45 (5): 523-528. doi:10.1111/j.1365-4632.2004.02533.x 12. Bertram F, Bröc